Servier Group

About Servier Group

Servier Group is a leading international pharmaceutical company headquartered in France, with a significant presence in the UK. Established in 1954, the company has grown to become a key player in the global healthcare landscape, dedicated to improving patient outcomes through innovative medicines.

With a strong focus on research and development, Servier invests heavily in discovering new therapeutic solutions across various therapeutic areas, including cardiology, oncology, diabetes, and psychiatry. The company’s commitment to innovation is reflected in its extensive portfolio of products that address unmet medical needs.

Servier operates in over 150 countries, employing more than 22,000 professionals worldwide. This diverse workforce is united by a common goal: to provide high-quality healthcare solutions that enhance the quality of life for patients.

The company’s vision is to be a trusted partner in health, striving to create value for patients, healthcare professionals, and society as a whole. Servier is committed to ethical practices and sustainability, ensuring that its operations contribute positively to the communities it serves.

In addition to its pharmaceutical activities, Servier is also involved in various initiatives aimed at promoting health education and awareness. The company collaborates with healthcare providers and organizations to support public health campaigns and improve access to essential medicines.

As a privately-held company, Servier maintains a long-term perspective on its business strategies, allowing it to focus on sustainable growth and innovation without the pressures of short-term financial performance.

Overall, Servier Group stands out as a dynamic and responsible player in the pharmaceutical industry, dedicated to advancing healthcare and making a meaningful impact on patients’ lives.